A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Janssen Research & Development, LLC Clinical Trial
Janssen Research & Development, LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
242 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fundaleu
Buenos Aires, Argentina
Active, not recruiting - Hospital Britanico de Buenos Aires
Buenos Aires, Argentina
Completed - Hospital Aleman
CABA, Argentina
Active, not recruiting
- Royal Adelaide Hospital
Adelaide, Australia
Active, not recruiting - Box Hill Hospital
Box Hill, Australia
Active, not recruiting - St Vincents Hospital
Darlinghurst, Australia
Active, not recruiting - St Vincents Hospital Melbourne
Fitzroy, Australia
Active, not recruiting - Gold Coast University Hospital
Southport, Australia
Active, not recruiting - Perth Blood Institute
West Perth, Australia
Active, not recruiting - Wollongong Hospital
Wollongong, Australia
Active, not recruiting
- Lkh - Universitätsklinikum Der Pmu Salzburg
Salzburg, Austria
Active, not recruiting - Klinik Ottakring
Vienna, Austria
Completed - Medical University Vienna Muv
Vienna, Austria
Completed
- Grand Hopital de Charleroi Site Les Viviers
Charleroi, Belgium
Active, not recruiting - Ziekenhuis Oost-Limburg
Genk, Belgium
Active, not recruiting - Ghent University Hospital
Ghent, Belgium
Active, not recruiting - Az Nikolaas - Campus Sint-Niklaas Moerland
Sint-Niklaas, Belgium
Active, not recruiting
- Cetus Oncologia
Belo Horizonte, Brazil
Active, not recruiting - Df Star
Brasília, Brazil
Active, not recruiting - Fundacao Universidade de Caxias Do Sul
Caxias do Sul, Brazil
Active, not recruiting - Hospital Erasto Gaertner- Liga Paranaense de Combate Ao Cancer
Curitiba, Brazil
Active, not recruiting - Hospital de Clinicas de Porto Alegre
Porto Alegre, Brazil
Completed - Instituto D Or de Pesquisa E Ensino Idor
Recife, Brazil
Active, not recruiting - Instituto de Educacao, Pesquisa E Gestao Em Saude Instituto Americas (coi)
Rio de Janeiro, Brazil
Active, not recruiting - Hospital Sao Rafael
Salvador, Brazil
Active, not recruiting - Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base
São José do Rio Preto, Brazil
Active, not recruiting - Clinica Medica Sao Germano S/s Ltda
São Paulo, Brazil
Active, not recruiting - Fundacao Antonio Prudente A C Camargo Cancer Center
São Paulo, Brazil
Active, not recruiting - Instituto D Or de Pesquisa E Ensino
São Paulo, Brazil
Active, not recruiting - Real E Benemerita Associacao Portuguesa de Beneficencia
São Paulo, Brazil
Active, not recruiting
- Arthur J E Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
Active, not recruiting - British Columbia Cancer Agency
Vancouver, British Columbia, Canada
Active, not recruiting - Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
Active, not recruiting - Juravinski Cancer Centre
Hamilton, Ontario, Canada
Active, not recruiting - Princess Margaret Cancer Centre University Health Network
Toronto, Ontario, Canada
Active, not recruiting - Ciusss de L Est de L Ile de Montreal Installation Hopital Maisonneuve Rosemont
Montreal, Quebec, Canada
Active, not recruiting - Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
Active, not recruiting
- Beijing Chaoyang Hospital
Beijing, China
Active, not recruiting - Peking University First Hospital
Beijing, China
Completed - Peking University People'S Hospital
Beijing, China
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jan 2024
- Primary completion
- 1 Apr 2026
- Completion
- 31 Dec 2028
- Last update posted
- 5 Jun 2026
- Registered enrollment
- 795
- Registry id
- NCT06208150
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.